Carbohydrate Metabolism, Inborn Errors
Dysfunctions of CARBOHYDRATE METABOLISM resulting from inborn genetic mutations that are inherited or acquired in utero.
Subtype terms (13)
More specific conditions that are subtypes of Carbohydrate Metabolism, Inborn Errors in the MeSH hierarchy.
- Congenital Disorders of Glycosylation
7 drugs (2 approved, 5 experimental)
- Fructose Metabolism, Inborn Errors
- Fucosidosis
11 drugs (8 approved, 3 experimental)
- Galactosemias
4 drugs (3 approved, 1 experimental)
- Glucosephosphate Dehydrogenase Deficiency
12 drugs (5 approved, 7 experimental)
- Glycogen Storage Disease
7 drugs (2 approved, 5 experimental)
- Hyperoxaluria, Primary
7 drugs (3 approved, 4 experimental)
- Lactose Intolerance
22 drugs (3 approved, 19 experimental)
- Mannosidase Deficiency Diseases
5 drugs (4 approved, 1 experimental)
- Mucolipidoses
7 drugs (6 approved, 1 experimental)
- Mucopolysaccharidoses
39 drugs (19 approved, 20 experimental)
- Multiple Carboxylase Deficiency
- Pyruvate Metabolism, Inborn Errors
Drugs by status
Approved for this indication (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (1)